compounded glp 1 injections GLP-1 / GIP Did the FDA Ban Compounded

Forecasting Methods Time-series modelling S-curve and diffusion models (for emerging technologies) Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes) Price elasticity models Market maturity and lifecycle-based projections Scenario Analysis Given inherent uncertainties, three scenarios were constructed: Base-Case Scenario: Expected trajectory under current conditions Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds Conservative Scenario: Slow adoption, regulatory delays, economic constraints Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption

For dichotomous outcomes, we calculated ORs and 95% CIs using the random-effects MantelHaenszel approach

AA: Data curation, Writing original draft

Market Scope: Global, with a primary focus on North America, which currently holds over 76% of the market share Grandviewresearch

The same improved glucose tolerance with increased GLP-1 and leptin levels was found in DPP4-depleted Dark Agouti rats with diet-induced obesity (46)

doi: 10.1152/ajpregu.1987.252.1.R160 38 KosinskiJRHubertJCarringtonPEChicchiGGMuJMillerCet al